Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bignotti

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Ophthalmic Genetics|September 27, 2023
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndromeKeri Mc Lean, Stefano Bignotti, Michele Callea, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control studyEmilio Di Maria, Rossella Gulli, Silvia Begni, et al.
Psychiatry Research|November 14, 2012
Structural brain features of borderline personality and bipolar disordersRoberta Rossi, Michela Pievani, Marco Lorenzi, et al.
Psychiatry Research. Neuroimaging|December 29, 2018
Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulationGiulia Quattrini, Lorenzo Pini, Michela Pievani, et al.
Journal of Affective Disorders|November 19, 2025
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatchAlessandro Serretti, Stefano Barlati, Lisa Buson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 24, 2025
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical settingAlessandra Minelli, Stefano Barlati, Stefano Bignotti, et al.
Trials|December 13, 2021
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)Alessandra Minelli, Stefano Barlati, Erika Vitali, et al.
Journal of Psychiatric Research|June 6, 2026
Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trialMaria Luca, Alessandro Serretti, Stefano Barlati, et al.
Psychiatry Research|January 4, 2026
Agitation and anxiety features define a more severe phenotype in unipolar depressionMaria Luca, Antonina Luca, Stefano Barlati, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Ophthalmic Genetics|September 27, 2023
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndromeKeri Mc Lean, Stefano Bignotti, Michele Callea, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 24, 2004
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control studyEmilio Di Maria, Rossella Gulli, Silvia Begni, et al.
Psychiatry Research|November 14, 2012
Structural brain features of borderline personality and bipolar disordersRoberta Rossi, Michela Pievani, Marco Lorenzi, et al.
Psychiatry Research. Neuroimaging|December 29, 2018
Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulationGiulia Quattrini, Lorenzo Pini, Michela Pievani, et al.
Journal of Affective Disorders|November 19, 2025
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatchAlessandro Serretti, Stefano Barlati, Lisa Buson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 24, 2025
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical settingAlessandra Minelli, Stefano Barlati, Stefano Bignotti, et al.
Trials|December 13, 2021
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)Alessandra Minelli, Stefano Barlati, Erika Vitali, et al.
Journal of Psychiatric Research|June 6, 2026
Symptom profiles at baseline are associated with remission in major depression: a confirmatory analysis of the PANDORA trialMaria Luca, Alessandro Serretti, Stefano Barlati, et al.
Psychiatry Research|January 4, 2026
Agitation and anxiety features define a more severe phenotype in unipolar depressionMaria Luca, Antonina Luca, Stefano Barlati, et al.
Pageof 3